232
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Optimization of propofol loaded niosomal gel for transdermal delivery

, , &
Pages 858-873 | Received 06 Dec 2020, Accepted 13 Jan 2021, Published online: 04 Feb 2021

References

  • Morgan DJ, Campbell GA, Crankshaw DP. Pharmacokinetics of propofol when given by intravenous infusion. Br J Clin Pharmacol. 1990;30(1):144–148.
  • Usher AG, Kearney RA, Tsui BC. Propofol total intravenous anesthesia for MRI in children. Pediatric Anesthesia. 2005;15(1):23–28.
  • Wehrmann T, Kokabpick S, Lembcke B, et al. Efficacy and safety of intravenous propofol sedation during routine ERCP: a prospective, controlled study. Gastrointestinal Endoscopy. 1999;49(6):677–683.,
  • Cohen LB, Dubovsky AN, Aisenberg J, et al. Propofol for endoscopic sedation: a protocol for safe and effective administration by the gastroenterologist. Gastrointestinal Endoscopy. 2003;58(5):725–732.,
  • Baker MT, Naguib M, Warltier DC. Propofol: the challenges of formulation. Anesthesiology. 2005;103(4):860–876.
  • Dundee J, Robinson FP, McCollum J, et al. Sensitivity to propofol in the elderly. Anaesthesia. 1986;41(5):482–485.,
  • Laxenaire M-C, Mata-Bermejo E, Moneret-Vautrin DA, et al. Life-threatening anaphylactoid reactions to propofol (Diprivan). Anesthesiology. 1992;77(2):275–280., ®),
  • Sommerfield D, Lucas M, Schilling A, et al. Propofol use in children with allergies to egg, peanut, soybean or other legumes. Anaesthesia. 2019;74(10):1252–1259.,
  • Hofer KN, McCarthy MW, Buck ML, et al. Possible anaphylaxis after propofol in a child with food allergy. Ann Pharmacother. 2003;37(3):398–401.,
  • Devaud J-C, Berger M, Pannatier A, et al. Hypertriglyceridemia: a potential side effect of propofol sedation in critical illness. Intensive Care Med. 2012;38(12):1990–1998.,
  • Charrière M, Ridley E, Hastings J, et al. Propofol sedation substantially increases the caloric and lipid intake in critically ill patients. Nutrition. 2017;42:64–68.,
  • Dhir A, Zolkowska D, Murphy RB, et al. Seizure protection by intrapulmonary delivery of propofol hemisuccinate. J Pharmacol Exp Ther. 2011;336(1):215–222.,
  • Hiraoka H, Yamamoto K, Okano N, et al. Changes in drug plasma concentrations of an extensively bound and highly extracted drug, propofol, in response to altered plasma binding. Clin Pharmacol Ther. 2004;75(4):324–330.,
  • Uchegbu IF, Jones M-C, Corrente F, et al. The oral and intranasal delivery of propofol using chitosan amphiphile nanoparticles. PNT. 2014;2(2):65–74.,
  • Najafabadi AH, Azodi-Deilami S, Abdouss M, et al. Synthesis and evaluation of hydroponically alginate nanoparticles as novel carrier for intravenous delivery of propofol. J Mater Sci Mater Med. 2015;26(3):145–155.
  • Wei Y, Qiu G, Lei B, et al. Oral delivery of propofol with methoxymethylphosphonic acid as the delivery vehicle. J Med Chem. 2017;60(20):8580–8590.,
  • Johnsson M, Barauskas J, Norlin A, et al. Physicochemical and drug delivery aspects of lipid-based liquid crystalline nanoparticles: a case study of intravenously administered propofol. J Nanosci Nanotechnol. 2006;6(9-10):3017–3024.,
  • Gaikwad AK. Transdermal drug delivery system: formulation aspects and evaluation. Comprehensive J Pharmaceut Sci. 2013;1(1):1–10.
  • Guy RH. Transdermal drug delivery, Drug delivery. Berlin, Heidelberg: Springer; 2010. pp. 399–410.
  • Thomas BJ, Finnin BC. The transdermal revolution. Drug Discov Today. 2004;9(16):697–703.
  • Tanner T, Marks R. Delivering drugs by the transdermal route: review and comment. Skin Res Technol. 2008;14(3):249–260.
  • Leppert W, Malec–Milewska M, Zajaczkowska R, et al. Transdermal and topical drug administration in the treatment of pain. Molecules. 2018;23(3):681.
  • Aboumanei MH, Mahmoud AF. Design and development of a proniosomal transdermal drug delivery system of caffeine for management of migraine: In vitro characterization, 131I-radiolabeling and in vivo biodistribution studies. Process Biochem. 2020;97:201–212.
  • Ouyang Q, Feng X, Kuang S, et al. Self-powered, on-demand transdermal drug delivery system driven by triboelectric nanogenerator. Nano Energy. 2019;62:610–619.,
  • Charoensumran P, Ajiro H. Controlled release of testosterone by polymer-polymer interaction enriched organogel as a novel transdermal drug delivery system: effect of limonene/PG and carbon-chain length on drug permeability. Reactive Funct Polym. 2020;148:104461.
  • Furuishi T, Kunimasu K, Fukushima K, et al. Formulation design and evaluation of a transdermal drug delivery system containing a novel eptazocine salt with the Eudragit® E adhesive. J Drug Deliv Sci Technol. 2019;54:101289.,
  • Patil SB, Inamdar SZ, Das KK, et al. Tailor-made electrically-responsive poly (acrylamide)-graft-pullulan copolymer based transdermal drug delivery systems: synthesis, characterization, in-vitro and ex-vivo evaluation. J Drug Deliv Sci Technol. 2020;56:101525.,
  • Kim H-S, Yun Y-H, Shim W-G, et al. Preparation of atenolol imprinted polysaccharide based biomaterials for a transdermal drug delivery system. J Drug Deliv Sci Technol. 2020;59:101893.,
  • Ramöller IK, Tekko IA, McCarthy HO, et al. Rapidly dissolving bilayer microneedle arrays – a minimally invasive transdermal drug delivery system for vitamin B12. Int J Pharm. 2019;566:299–306.,
  • Maulvi FA, Parmar RJ, Desai AR, et al. Tailored gatifloxacin Pluronic® F-68-loaded contact lens: Addressing the issue of transmittance and swelling. Int J Pharm . 2020; 581) :119279.
  • Maulvi FA, Bodaa AM, Desai AR, et al. Application of Box-Behnken design in optimization of ibuprofen ternary solid dispersion. J Pharmacy Appl Sci. 2015;2(2):1–11.,
  • Nowroozi F, Almasi A, Javidi J, et al. Effect of surfactant type, cholesterol content and various downsizing methods on the particle size of niosomes. Iran J Pharmaceut Res. 2018;17(12):1–15.,
  • Khan DH, Bashir S, Figueiredo P, et al. Process optimization of ecological probe sonication technique for production of rifampicin loaded niosomes. J Drug Deliv Sci Technol. 2019;50:27–33.,
  • Yeo LK, Chaw CS, Elkordy AA. The effects of hydration parameters and co-surfactants on methylene blue-loaded niosomes prepared by the thin film hydration method. Pharmaceuticals. 2019;12(2):46–56.
  • Diskaeva E, Vecher O, Bazikov I, et al. Particle size analysis of niosomes as a function of temperature. Nanosystems. 2018;9(2):1–15.,
  • Zhang Y, Jing Q, Hu H, et al. Sodium dodecyl sulfate improved stability and transdermal delivery of salidroside-encapsulated niosomes via effects on zeta potential. Int J Pharm. 2020; 580:119183.
  • García-Manrique P, Machado ND, Fernández MA, et al. Effect of drug molecular weight on niosomes size and encapsulation efficiency. Colloids Surf B Biointerfaces. 2020;186:110711
  • Talebi V, Ghanbarzadeh B, Hamishehkar H, et al. Effects of different stabilizers on colloidal properties and encapsulation efficiency of vitamin D3 loaded nano-niosomes. J Drug Deliv Sci Technol. 2019;101284.
  • Fontana M, Bastos M, Beck R. Development and validation of a fast RP-HPLC method for the determination of clobetasol propionate in topical nanocapsule suspensions. J Chromatogr Sci. 2010;48(8):637–640.
  • Pandey SS, Maulvi FA, Patel PS, et al. Cyclosporine laden tailored microemulsion-gel depot for effective treatment of psoriasis: In vitro and in vivo studies. Colloids Surfaces B: Biointerfaces. 2020;186:110681.,
  • Desai AR, Maulvi FA, Desai DM, et al. Multiple drug delivery from the drug-implants-laden silicone contact lens: addressing the issue of burst drug release. Materials Science Engineering: C. 2020;112:110885.
  • Numin MS, Jumbri K, Ramli A, et al. Microemulsion rheological analysis of alkaline, surfactant, and polymer in oil-water interface. Processes. 2020;8(7):762.,
  • Jagdale S, Pawar S. Gellified emulsion of ofloxacin for transdermal drug delivery system. Adv Pharm Bull. 2017;7(2):229–239.
  • Patel H, Panchal M, Shah S, et al. Formulation and evaluation of transdermal gel of sildenafil citrate. Int J Pharmaceut Res Allied Sci. 2012;1(3):103–118.
  • Li H, Jia Y, Liu C. Pluronic® F127 stabilized reduced graphene oxide hydrogel for transdermal delivery of ondansetron: Ex vivo and animal studies. Colloids Surf B Biointerfaces. 2020;195:111259
  • Malakar J, Sen SO, Nayak AK, et al. Development and evaluation of microemulsions for transdermal delivery of insulin. ISRN Pharm. 2011;:780150–780157.
  • Aziz DE, Abdelbary AA, Elassasy AI. Investigating superiority of novel bilosomes over niosomes in the transdermal delivery of diacerein: in vitro characterization, ex vivo permeation and in vivo skin deposition study. J Liposome Res. 2019;29(1):73–85.
  • Maulvi FA, Pillai LV, Patel KP, et al. Lidocaine tripotassium phosphate complex laden microemulsion for prolonged local anaesthesia: In vitro and in vivo studies. Colloids Surfaces B: Biointerfaces. 2020;185:110632.,
  • Gugleva V, Titeva S, Rangelov S, et al. Design and in vitro evaluation of doxycycline hyclate niosomes as a potential ocular delivery system. Int J Pharm. 2019;567:118431.
  • He R-X, Ye X, Li R, et al. PEGylated niosomes-mediated drug delivery systems for Paeonol: preparation, pharmacokinetics studies and synergistic anti-tumor effects with 5-FU. J Liposome Res. 2017;27(2):161–170.,
  • Pawar S, Shevalkar G, Vavia P. Glucosamine-anchored doxorubicin-loaded targeted nano-niosomes: pharmacokinetic, toxicity and pharmacodynamic evaluation. J Drug Targeting. 2016;24(8):730–743.
  • Lee S-C, Lee K-E, Kim J-J, et al. The effect of cholesterol in the liposome bilayer on the stabilization of incorporated retinol. J Liposome Res. 2005;15(3-4):157–166.,
  • Essa EA. Effect of formulation and processing variables on the particle size of sorbitan monopalmitate niosomes. Asian J Pharm. 2010;4(4):227–233.
  • Sun J, Wang F, Sui Y, et al. Effect of particle size on solubility, dissolution rate, and oral bioavailability: evaluation using coenzyme Q10 as naked nanocrystals. Int J Nanomedicine. 2012;7:5733–5744.,
  • Moghassemi S, Hadjizadeh A. Nano-niosomes as nanoscale drug delivery systems: an illustrated review. J Control Release. 2014;185:22–36.
  • Clogston JD, Patri AK. Zeta potential measurement, characterization of nanoparticles intended for drug delivery. New Jersey: Humana Press; 2011, pp. 63–70.
  • Pandey SS, Patel MA, Desai DT, et al. Bioavailability enhancement of repaglinide from transdermally applied nanostructured lipid carrier gel: Optimization, in vitro and in vivo studies. J Drug Deliv Sci Technol. 2020;57:101731.
  • Li Q, Li F, Qi X, et al. Pluronic® F127 stabilized reduced graphene oxide hydrogel for the treatment of psoriasis: In vitro and in vivo studies. Colloids Surf B Biointerfaces. 2020;195:111246
  • Juluri A, Murthy SN. Transdermal iontophoretic delivery of a liquid lipophilic drug by complexation with an anionic cyclodextrin. J Control Release. 2014;189:11–18.
  • Akhtar N, Arkvanshi S, Bhattacharya SS, et al. Preparation and evaluation of a buflomedil hydrochloride niosomal patch for transdermal delivery. J Liposome Res. 2015;25(3):191–201.,
  • Wagh VD, Deshmukh OJ. Itraconazole niosomes drug delivery system and its antimycotic activity against Candida albicans. Int Sch Res Notices. 2012;2012:1–7.
  • Abdelkader H, Alani AW, Alany RG. Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations. Drug Deliv. 2014;21(2):87–100.
  • Juluri A, Peddikotla P, Repka MA, et al. Transdermal iontophoretic delivery of propofol: a general anaesthetic in the form of its phosphate salt. J Pharm Sci. 2013;102(2):500–507.,
  • Siegel I, Gordon H. Surfactant-induced increases of permeability of rat oral mucosa to non-electrolytes in vivo. Arch Oral Biol. 1985;30(1):43–47.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.